← Amphastar Pharmaceuticals, Inc. AMPH
Market Price
$20.94
Market Cap
$889.79M
P/E Ratio
10.32
Revenue (FY 2025)
↓-1.7% YoY
$719.89M
3-Yr CAGR: 13.0%
Net Income
↓-38.5% YoY
$98.09M
Net Margin: 13.6%
Free Cash Flow
↓-29.7% YoY
$121.23M
FCF Yield: 13.62%
EPS (Diluted)
↓-33.7% YoY
$2.03
Basic: $2.10
Return on Equity
Efficiency
22.0%
ROA: 745.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (AMPH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $255.2M | — | $104.2M | $10.5M | — | $0.22 | — | $38.6M | $17.2M | — |
| FY 2017 | $240.2M | -5.9% | $90.8M | $4.5M | -57.2% | $0.09 | -59.1% | $39.2M | $4.1M | -76.1% |
| FY 2018 | $294.7M | +22.7% | $107.0M | $-5.7M | -227.3% | $-0.12 | -233.3% | $38.2M | $-8.6M | -309.7% |
| FY 2019 | $322.4M | +9.4% | $131.9M | $48.9M | +952.9% | $0.98 | +916.7% | $41.8M | $0.2M | +102.4% |
| FY 2020 | $349.8M | +8.5% | $143.3M | $1.4M | -97.1% | $0.03 | -96.9% | $57.3M | $23.4M | +11,209.7% |
| FY 2021 | $437.8M | +25.1% | $199.7M | $62.1M | +4,327.4% | $1.25 | +4,066.7% | $98.0M | $70.5M | +201.3% |
| FY 2022 | $499.0M | +14.0% | $248.9M | $91.4M | +47.1% | $1.74 | +39.2% | $89.2M | $65.1M | -7.6% |
| FY 2023 | $644.4M | +29.1% | $351.1M | $137.5M | +50.5% | $2.60 | +49.4% | $183.5M | $145.3M | +123.1% |
| FY 2024 | $732.0M | +13.6% | $373.9M | $159.5M | +16.0% | $3.06 | +17.7% | $213.4M | $172.3M | +18.6% |
| FY 2025 | $719.9M | -1.7% | $356.1M | $98.1M | -38.5% | $2.03 | -33.7% | $156.1M | $121.2M | -29.7% |
Valuation
Market Price
$20.94
Market Cap
$889.79M
Enterprise Value
$1.34B
P/E Ratio
10.32
P/B Ratio
2.07
FCF Yield
13.62%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
49.46%
Operating Margin
19.50%
Net Margin
13.63%
Return on Equity (ROE)
22.02%
Return on Assets (ROA)
745.85%
Asset Turnover
54.74x
Revenue 3-Yr CAGR
12.99%
Financial Health & Liquidity
Current Ratio
0.11
Cash Ratio
1.47
Debt / Equity
1.391
Debt / Assets
47.119
Cash & Equivalents
$170.18M
Total Debt
$619.71M
Book Value / Share
$10.10
Cash Flow Efficiency
Operating Cash Flow
$156.12M
Capital Expenditures (CapEx)
$34.88M
Free Cash Flow
$121.23M
OCF / Revenue
21.69%
FCF / Revenue
16.84%
FCF 3-Yr CAGR
23.00%
Per Share Metrics
EPS (Diluted)
$2.03
EPS (Basic)
$2.10
Dividends / Share
N/A
Book Value / Share
$10.10
EPS YoY Growth
-33.66%
Balance Sheet (FY 2025)
Total Assets
$13.15M
Total Liabilities
$115.76M
Stockholders' Equity
$445.52M
Current Assets
$13.15M
Current Liabilities
$115.76M